Article
Presence of novel triple mutations in the pvdhfr from Plasmodium vivax in Mangaluru city area in the southwestern coastal region of India.
Malaria journal - 16 Apr 2018
Joy Shiny, Ghosh Susanta K, Achur Rajeshwara N, Gowda D Channe, Surolia Namita
Abstract excerpt
BACKGROUND: Genes encoding dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) are the targets of sulfadoxine-pyrimethamine (SP) present in artemisinin based combination therapy (ACT; artesunate + sulfadoxine pyrimethamine) for Plasmodium falciparum. Although SP is generally not used to treat vivax infection, mutations in dhfr and dhps that confer antifolate resistance in Plasmodium vivax are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
